WO2012118687A1 - Injecteur actionné manuellement avec séquence d'injection limitée - Google Patents

Injecteur actionné manuellement avec séquence d'injection limitée Download PDF

Info

Publication number
WO2012118687A1
WO2012118687A1 PCT/US2012/026239 US2012026239W WO2012118687A1 WO 2012118687 A1 WO2012118687 A1 WO 2012118687A1 US 2012026239 W US2012026239 W US 2012026239W WO 2012118687 A1 WO2012118687 A1 WO 2012118687A1
Authority
WO
WIPO (PCT)
Prior art keywords
plunger
sleeve
medicament
injector
outer casing
Prior art date
Application number
PCT/US2012/026239
Other languages
English (en)
Inventor
Annaniy Berenshteyn
Mikhail Gotliboym
Wail Rasheed
Aleksandr Zuyev
Original Assignee
Merck Sharp & Dohme Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp. filed Critical Merck Sharp & Dohme Corp.
Publication of WO2012118687A1 publication Critical patent/WO2012118687A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2448—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3146—Priming, e.g. purging, reducing backlash or clearance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A61M5/31553—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe without axial movement of dose setting member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3156—Mechanically operated dose setting member using volume steps only adjustable in discrete intervals, i.e. individually distinct intervals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/3157—Means providing feedback signals when administration is completed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2448—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing
    • A61M2005/2451—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing preventing delivery before mixing is completed, e.g. by locking mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
    • A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button

Definitions

  • the present invention generally relates to devices for injecting a medicament into a patient. More particularly, the present invention relates to manually operated injection devices that restrict users from performing certain steps of an injection sequence out of order.
  • Typical manual injectors however, also have a shortcoming: they allow a user to perform the various steps of an injection sequence out of order. For example, a user of these devices may forget to prime the injector before injection or otherwise omit or misplace a key step in the injection sequence. Although these devices are typically less complex and costly than many auto-injection devices, failure to use manual injectors in their intended manner can result in a reduced efficiency or, in some cases, can potentially harm the user.
  • Certain embodiments of the present invention generally relate to an injector.
  • the injector includes a medicament cartridge containing at least one medicament, a first piston located within the medicament cartridge, an outer casing configured to receive the medicament cartridge therein, an attachment mechanism at a distal end of the outer casing (wherein the attachment mechanism is configured to receive a needle assembly), a release adaptor provided within the outer casing and outside of the medicament cartridge, a plunger sleeve provided at least partially within the outer casing, a plunger provided at least partially within the plunger sleeve, the outer casing, and the dose setting sleeve, the plunger axially slidable relative to the outer casing and configured to engage with the first piston, and a sleeve lock having at least one flexible detent that prevents distal movement of the plunger sleeve in an initial position of the injector.
  • the release adaptor slides in the proximal direction, thereby flexing the at least one flexible detent of the sleeve lock and allowing distal movement of the plunger sleeve beyond the initial position. Accordingly, a user of the injector is prevented from priming the injector or injecting a medicament until a needle assembly is attached.
  • an injector having a medicament cartridge containing at least one solid and one liquid medicament, a first piston located within the medicament cartridge, an outer casing configured to receive the medicament cartridge therein, an attachment mechanism at a distal end of the outer casing (wherein the attachment mechanism is configured to receive a needle assembly), a release adaptor provided within the outer casing and outside of the medicament cartridge, a plunger sleeve provided at least partially within the outer casing, a dose setting sleeve provided on an outer circumferential surface of the plunger sleeve and rotatably fixed to the plunger sleeve, a plunger provided at least partially within the plunger sleeve, the outer casing, and the dose setting sleeve (the plunger axially slidable relative to the outer casing and configured to engage with the first piston), a sleeve lock having at least one flexible detent that prevents distal movement of the plunger sleeve in an initial position,
  • the finger of the plunger sleeve Prior to the mixing of the solid and liquid medicaments, the finger of the plunger sleeve is prevented from contracting into the groove of the plunger by a distal circumferential surface toward the distal end of the plunger, and the release adaptor is prevented from moving proximally by contact of the finger with an inwardly-protruding surface at the proximal end of the release adaptor.
  • the finger contracts into the groove of the plunger, thereby allowing proximal movement of the release adaptor.
  • a proximal surface of the needle assembly pushes the one or more protrusions through the one or more through holes of the outer casing, which slides the release adaptor in the proximal direction, thereby flexing the at least one flexible detent of the sleeve lock and allowing distal movement of the plunger sleeve beyond the initial position. Accordingly, a user of the injector is then allowed to perform a priming step. Further, a proximal-most surface of the rear body prevents distal movement of the key guide (and therefore the plunger sleeve) when the injector is in a primed state prior to setting a dose.
  • Rotation of the dose setting sleeve rotates the plunger sleeve to align the key guide with one of the plurality of dosing grooves, thereby allowing further distal movement of the key guide. Accordingly, after rotating the dose setting sleeve, a user can begin injection.
  • Still other embodiments of the present invention relate to a method of injecting a medicament.
  • One such method includes the steps of providing an injector having an outer casing including an attachment mechanism at a distal end of the outer casing and configured to receive a needle assembly, a medicament cartridge including at least one medicament and provided within the outer casing, a release adaptor axially slidable within the outer casing and including one or more protrusions configured to protrude through one or more through holes provided on a proximal end of the outer casing, a plunger sleeve provided at least partially within the outer casing, and a sleeve lock including at least one flexible detent that prevents distal movement of the plunger sleeve in an initial position; attaching a needle assembly to the attachment mechanism, wherein the attaching the needle assembly causes distal movement of the release adaptor by forcing the one or more protrusions of the release adaptor through the one or more through holes of the outer casing, wherein the distal movement of the release adaptor
  • FIG. 1 shows a perspective view of an injector in the initial position, in accordance with an embodiment of the present invention
  • FIG. 2 shows an exploded perspective view of the injector of FIG. 1 ;
  • FIG. 3A shows a cross-sectional view of an injector in an initial position
  • FIG. 3B shows a cross-sectional view of the injector of FIG. 3 A rotated 90 degrees
  • FIG. 3C shows an enlarged cross-sectional view of the injector of FIG. 3 A
  • FIG. 4 shows a cross-sectional view of an injector at the start of a mixing phase
  • FIG. 5 shows a cross-sectional view of an injector at the completion of the mixing phase
  • FIG. 6A shows a side view of an injector and a needle assembly after completion of a mixing phase but prior to attachment of the needle assembly
  • FIG. 6B shows a perspective view of the injector in FIG. 6A
  • FIG. 6C shows a perspective view of the injector of FIGS. 6A and 6B after the needle assembly has been attached and a needle sheath has been removed;
  • FIG. 7 shows a cross-sectional view of the injector of FIGS. 6A - 6C;
  • FIG. 8A shows a cross-sectional view of an injector at the completion of a priming phase
  • FIG. 8B shows a rear perspective view of certain components of the injector of
  • FIG. 8A
  • FIG. 9A shows a rear perspective view of an injector set to a dose
  • FIG. 9B shows an additional rear perspective view of certain components of the injector of FIG. 9A;
  • FIG. 10 shows a front perspective view of certain components of the injector ofFIGS. 9A and 9B; [0026] FIG. 11 A shows a cross-sectional view of an injector that has completed an injection; and
  • FIG. 1 IB shows a cross-sectional, perspective view of the injector of FIG.
  • distal refers to the end of a device or component closest to the end to be applied to a patient: that is, the needle end.
  • distal similarly refers to movement towards the injector's needle end.
  • proximal or proximally refer to the end or direction opposed to the injector's needle end.
  • distal direction is to the left, while the proximal direction is to the right.
  • the axial direction refers to the longitudinal axis of the device, such that axial movement implies movement in either a distal or proximal direction.
  • Certain embodiments of the present invention generally relate to an injector for injecting a medicament into an injection site, such as on a patient.
  • a user of the injector is prevented from attaching a needle assembly prior to completing the mixing of two or more medicaments within the injector. Also, a user cannot prime the injector or inject a
  • certain embodiments of the present invention prohibit a user from performing steps of an injection sequence out of order.
  • an injector 1 includes a medicament cartridge 10, an outer casing 20, a release adaptor 30, a plunger sleeve 40, a plunger 50, a rear body 60, a sleeve lock 70, and a dose setting sleeve 80.
  • a medicament cartridge 10 an outer casing 20
  • a release adaptor 30 a plunger sleeve 40
  • a plunger 50 a plunger 50
  • a rear body 60 a sleeve lock 70
  • a dose setting sleeve 80 a dose setting sleeve 80.
  • Medicament cartridge 10 contains at least one medicament and at least one piston.
  • Medicament cartridge 10 is preferably a dual-chamber cylinder ampoule or two- compartment syringe having a generally cylindrical shape. That is, preferably, cartridge 10 provides two medicaments separately from one another.
  • the medicaments may be kept separate from one another by a first piston 11 and a second piston 12 located distal to first piston 11, as shown in FIG. 2.
  • the proximal end of first piston 11 may be configured to engage with a distal end 51 of plunger 50.
  • the pistons may be configured to force medicament out of a distal opening of cartridge 10 by advancing distally.
  • the distal end of cartridge 10. may include a pierceable septum, membrane, or cover that keeps medicament inside the cartridge until a needle is attached.
  • Medicament cartridge 10 may also include an overflow channel 14.
  • Channel 14 may also include an overflow channel 14.
  • 14 is configured to allow a liquid medicament 15 contained between first and second pistons 11 and 12 to advance distally past second piston 12 when second piston 12 advances to channel 14. This allows a liquid medicament/solvent 15 to mix with a solid
  • medicament/solute 17 located distal to second piston 12.
  • a broad range of medicaments may be used in the present invention.
  • the at least one medicament contained in the cartridge may be a solid, a liquid, or any other phase. Additionally, any combination of solid, liquid, or other medicaments may be used.
  • the cartridge contains a solid medicament, which comprises a therapeutic agent, and a liquid medicament, which lacks therapeutic activity, but instead consists of one, two, three or more exicipients.
  • the liquid medicament may consist of a diluent.
  • the diluent is Sterile Water for Injection, USP.
  • the diluent is a buffered solution.
  • the solid medicament is a lyophilized powder comprising at least one peptide, polypeptide or protein as the therapeutic agent and one two, three or more exicipients.
  • the peptide, polypeptide or protein may comprise one or more polymer molecules, such as polyethylene glycol, conjugated to the amino acid molecule.
  • the solid medicament may comprise at least one antigen for use as a vaccine.
  • the solid medicament comprises an antibody, an antigen binding fragment of an antibody, a receptor:Fc fusion protein, or a cytokine.
  • the solid medicament comprises a pegylated interferon alfa and is approved by a regulatory agency for treating infection with hepatitis C virus.
  • the solid medicament is PegIntron® (Peginterferon alfa-2b) Powder for Injection and the liquid medicament is water.
  • Peglntron® Powder for Injection
  • PEG 12,000 monomethoxy polyethylene glycol having an average molecular weight of 12,000 daltons
  • exicipients dibasic sodium phosphate anhydrous; monobasic sodium phosphate dehydrate, sucrose and polysorbate 80.
  • the liquid medicament chamber contains 0.7 ml water and the solid medicament chamber contains 67.5 ⁇ g, 108 ⁇ g, 162 ⁇ g, or 202.5 ⁇ g of peginterferon alfa-2b, 1.013 mg dibasic sodium phosphate anhydrous, 1.013 mg monobasic sodium phosphate dihydrate, 54 mg sucrose and 0.0675 mg polysorbate 80.
  • Medicament cartridge 10 may be constructed of any material suitable for use in an injector.
  • Cartridge 10 may be made of a transparent or translucent material, allowing a user to view the contents of the cartridge.
  • Cartridge 10 may also be opaque.
  • Cartridge 10 may further include hash marks thereon for allowing a user to determine the amount of medicament or the position of the pistons within medicament cartridge 10.
  • Medicament cartridge 10 is fixedly provided within outer casing 20.
  • medicament cartridge 10 may be removable from outer casing 20 so that injector 1 may be reused with a new medicament cartridge.
  • Cartridge 10 may either be directly attached to the inner circumferential surface of outer casing 20, or indirectly attached through release adaptor 30. In certain embodiments, cartridge 10 may be rotatably and/or axially fixed to outer casing 20.
  • a portion of injector 1 's exterior is formed by outer casing 20.
  • Outer casing 20 preferably defines an inner space for receiving various other components of injector 1, such as medicament cartridge 10 and lock sleeve 70.
  • Outer casing 20 may include a viewing window 23 that allows a user to view the contents of medicament cartridge 10.
  • Casing 20 may also include, at its distal end, one or more through holes 21 that communicate with casing 20's inner space. Viewing window 23 and through holes 21 may be of any suitable size and shape. Additionally, viewing window 23 may include hash marks thereon or thereabout for allowing a user to determine the amount of medicament or the position of the pistons within medicament cartridge 10.
  • Viewing window 23 need not be a physical component, such as a transparent or translucent piece of plastic; alternatively, it may also be a through hole that allows a user to view cartridge 10 contained within casing 20.
  • Outer casing 20 also provides wings 27 that allow for a user to handle injector
  • Wings 27 may have a distal-facing surface that is at least partially concave, further increasing the ease of handling and use. Wings 27 may also have a flat distal-facing surface.
  • outer casing 20 contains a hole that communicates with the inner space of casing 20. During injection, medicament travels through this hole (via a needle) to the injection site.
  • the distal-most end of outer casing 20 also includes an attachment mechanism 25 for attaching a needle assembly to the outer casing.
  • Attachment mechanism 25 is preferably configured to receive a needle assembly.
  • Attachment mechanism 25 may be internal or external threads that engage with corresponding threads on a needle assembly.
  • attachment mechanism 25 may be a snap or luer lock connection.
  • Attachment mechanism 25 may also be any other mechanism known in the art and suitable for attaching a needle assembly to an injector.
  • outer casing 20 may include means for attaching a needle assembly to the outer casing, which may have a configuration similar to the attachment mechanism.
  • Outer casing 20 has attached, at its proximal end, rear body 60.
  • Rear body 60 may be fixedly attached or snapped to the proximal end of outer casing 20. (Alternatively, rear body 60 may be formed integrally with outer casing 20.)
  • rear body 60 includes a plurality of dosing grooves 61a, 61b, 61c, and 6 Id (collectively, 61). Grooves 61 are configured to allow key guide 41 of sleeve 40 to pass through. Each groove is of a different length, corresponding to the dose associated with the particular groove. Larger doses will have longer dosing grooves, while smaller doses will have shorter dosing grooves. This is best shown by comparing groove 61a to groove 61 d in FIG. 1 IB.
  • rear body 60 includes one dosing groove for each dose selectable by a user.
  • an injector capable of six different doses is shown in the figures, any number of doses of a suitable size and increment are possible.
  • an injector in accordance with the present invention may provide a dose range of 0.2 - 0.5 mL, with dose increments of 0.1 mL. Other ranges and increments, however, are also possible.
  • rear body 60 includes a plurality of click grooves 63a, 63b, 63c, and
  • Click grooves 63 are configured to engage with detent 45 on plunger sleeve 40 to provide haptic and/or audible feedback during dose setting. That is, a user feels a slight vibration and/or hears a click as dose setting sleeve 80 is rotated to each dose.
  • Click grooves 63 may be of equal length, as shown in FIG. 1 IB. Alternatively, these grooves may vary in length or depth as needed.
  • Rear body 60 may also include a plurality of dose indicating marks 62 on its proximal surface, as best shown in FIGS. 8B and 9A. These marks aide a user in identifying and selecting a dose.
  • Rear body 60 may also include wings 67 that fit inside wings 27 of outer casing 20, as shown in FIGS. 2 and 4.
  • release adaptor 30 is provided between outer casing 20 and medicament cartridge 10.
  • Release adaptor 30 may be a sleeve- or tube-like component that is axially slidable relative to outer casing 20 and medicament cartridge 10. That is, release adaptor 30 is capable of both distal and proximal movement relative to outer casing 20. Release adaptor 30 is suitably configured to allow for viewing of cartridge 10 through viewing window 23 of outer casing 20.
  • release adaptor 30 includes one or more protrusions 31 configured to pass through the one or more holes 21 in outer casing 20. In the initial position, protrusions 31 protrude through holes 21. A cover or other suitable component may enclose or otherwise shield protrusions 31 to prevent inadvertent pressing of protrusions 31 prior to attaching a needle assembly.
  • adaptor 30 includes tabs 33 configured to push apart one or more detents 73 on sleeve lock 70 (to be described later). In general, release adaptor 30 extends beyond medicament cartridge 10 in both the proximal and distal directions, as shown in FIG. 3 A.
  • Release adaptor 30 may further include an inwardly-protruding surface 35, as best seen in FIG. 3C.
  • Surface 35 preferably protrudes radially inward so as to contact a portion of plunger sleeve 40. This contact prevents proximal movement of release adaptor 30 until the completion of a mixing step.
  • plunger sleeve 40 is provided.
  • Plunger sleeve 40 may be a hollow sleeve- or tube-like component. Plunger sleeve 40 is configured to receive plunger 50 therein. Accordingly, plunger sleeve 40 may have an inner cross-sectional profile that matches that cross-section of plunger 50. Preferably, plunger sleeve 40 has a circular outer circumferential surface, such that it is able to rotate within outer casing 20. [0057] Plunger sleeve 40 is also configured to engage with rear body 60, sleeve lock
  • plunger sleeve 40 includes a flexible detent 45.
  • Detent 45 prevents backup of the sleeve after injection is complete.
  • Detent 45 also provides haptic and/or audible feedback (such as clicking) to a user during dose setting by engaging with click grooves 63 as shown in FIG. 10.
  • Plunger sleeve 40 further includes a key guide 41 , which may be a solid, raised projection on an outer circumferential surface of sleeve 40. As best seen in FIGS. 8A and 8B, key guide 41 prevents distal movement of plunger sleeve 40 after priming but prior to dose setting. Key guide 41 is also sized and shaped so as to be accommodated by dosing grooves 61 of rear body 60.
  • Plunger sleeve 40 also includes a plurality of dose end tabs 47a, 47b, 47c, 47d, and 47e (collectively, 47) around its outer circumference toward its distal end, as shown in FIGS. 10 and 11 A.
  • Tabs 47 are of various widths based on the dose selected by a user.
  • Tabs 47 in conjunction with an end-of-dose-indicating tab 71 on sleeve lock 70, provide haptic and/or audible feedback to a user at the end of injection.
  • tabs 47 prevent plunger sleeve 40 from backing out in the proximal direction after injection has completed.
  • Plunger sleeve 40 further includes a finger 49 that extends axially from its distal end. Finger 49 is preferably flexible. Finger 49 is configured to "snap" or otherwise contract into a longitudinal groove 55 on the outer circumferential surface of plunger 50. As described in detail later, the contact of finger 49 with plunger 50 prevents a user from attaching a needle assembly to injector 1 before the medicaments have fully mixed.
  • this contact prevents a user from performing subsequent steps (such as attaching a needle assembly) prior to completing a mixing step.
  • plunger 50 Partially disposed within plunger sleeve 40, is plunger 50.
  • Plunger 50 is preferably of a cylindrical shape and may include a latch 52 for engaging with plunger sleeve 40.
  • Plunger 50 need not have a circular cross-section, however. Rather, plunger 50 may be of a non-circular shape in order to prevent rotation of the plunger within plunger sleeve 40.
  • Latch 52 prevents backup of plunger 50.
  • Plunger 50 may also have a distal end surface 51 configured to engage with first piston 11. Further, plunger 50 may include a proximal end having a larger diameter than the rest of plunger 50.
  • plunger SO includes longitudinal groove 55 on its outer circumferential surface, as best seen in FIG. 3C.
  • Groove 55 may be of any size, length, width, and shape suitable to the particular application.
  • groove 55 is configured to allow finger 49 to slide axially therein.
  • plunger 50 also includes a distal circumferential surface 57 between the distal-most end of groove 55 and distal end surface 51.
  • surface 57 prevents finger 49 from snapping or otherwise contracting into groove 55.
  • the length of surface 57 may be varied to ensure that complete mixing of the medicaments in cartridge 10 takes place prior to finger 49 engaging in groove 55 and releasing release adaptor 30.
  • the length of surface 57 may be determined based on a desire to limit other steps of an injection sequence.
  • Sleeve lock 70 is provided inside outer casing 20 between release adaptor 30 and outer casing 20 toward the casing's proximal end, as shown in FIG. 3A.
  • Sleeve lock 70 engages with outer casing 20 such that it is both rotatably and axial fixed to casing 20.
  • sleeve lock 70 is formed integrally with outer casing 20.
  • sleeve lock 70 is a separate component
  • Sleeve lock 70 may include a flexible, end-of-dose-indicating tab 71, as best seen in FIG. 11 A.
  • Sleeve lock 70 further includes one or more flexible detents 73, as best seen in FIGS. 3 A and 7, that prevent distal movement of plunger sleeve 40 until a user attaches a needle assembly.
  • Flexible detent 73 may be a fingerlike member.
  • Dose setting sleeve 80 is rotatably locked to plunger sleeve 40 via one or more grooves 43 on plunger sleeve 40, as best seen in FIG. 8B. These grooves engage with tabs or similar protrusions on dose setting sleeve 80 to rotatably couple the two components to one another. Thus, rotation of dose setting sleeve 80 results in rotation of plunger sleeve 40.
  • Dose setting sleeve 80 may include a marker 83 or similar visual aid to assist the user in selecting a dose, as best seen in FIG. 9A. Further, dose setting sleeve 80 may have grooves or raised projections on its outer circumferential surface that aide a user in rotating dose setting sleeve 80.
  • Injector 1 is configured to receive, via attachment mechanism 25, a needle assembly 90, as shown in FIGS. 6A - 6C.
  • Needle assembly 90 may include a needle sheath 91 for protecting individuals handling injector 1 or assembly 90 from a needle 93.
  • Needle 93 may be of any suitable gauge and length.
  • needle 93 is a double-ended needle so that, upon attaching needle assembly 90 to outer casing 20, the proximal end of needle 93 pierces the septum/membrane of medicament cartridge 10, as shown in FIG. 7.
  • Needle 93 preferably includes an internal lumen that delivers medicament from cartridge 10 to an injection site.
  • the proximal end of needle assembly 90 includes a mechanism or means
  • attachment mechanism 25 of the outer casing (such as threads or a luer lock) configured to engage with attachment mechanism 25 of the outer casing.
  • the injector need not include springs, pressurized chambers, or other means for automatic movement of one or more components. Although a manual injector has been described, however, the principles of the present invention may also be applied to auto- injectors.
  • the injector is used by the patient, but it may also be used by medical professionals, such as doctors and nurses, or the patient's family members.
  • medical professionals such as doctors and nurses, or the patient's family members.
  • an injector is described throughout, the principles of the present invention may also be applied to a patient trainer for training users on the injection procedure for an actual injector.
  • a variable dose injector is described, the principles of the present invention may also be applied to a fixed dose injector.
  • An injector in accordance with other embodiments of the present invention may be disposable or reusable.
  • the injector is a dual-chamber cylinder ampoule (or "two compartment") injection device that mixes a solid medicament or solute with a liquid medicament or solvent prior to injection.
  • dual-chambered does not necessarily mean that separate medicament containers are provided in the injector. Rather, this term preferably describes a medicament container— such as medicament cartridge 10 in FIG. 2— in which the solid and liquid medicaments are separated by one or more pistons.
  • the injector may also include electronic components that display a selected dose to a user, provide audible feedback, or otherwise assist in the injection sequence.
  • These electronic components may include a database that stores use data or other user information.
  • the components may include an interface—such as a universal serial bus (USB)— that allows the data to be sent to a computer or other electronic device.
  • the components may also include transmitters capable of wirelessly transferring data from the injector to a separate electronic device. These electronic components will have appropriate programming to carry out their respective functions.
  • the above components described in sections 1 - 9 and shown in the figures may be made of any material suitable for injectors and similar devices.
  • the various components are made of lightweight materials such as plastics.
  • Operation of injector 1 includes five basic steps: mixing, needle attachment, priming, dose setting, and injection. First, an initial position of injector 1 is described. Then each of the steps in the injection sequence is discussed in detail.
  • FIGS. 3A - 3C depict injector 1 in an initial position. In this position, plunger
  • plunger sleeve 40 In the initial position shown in FIGS. 3A and 3B, plunger sleeve 40 is prevented from advancing distally by flexible detents 73 of sleeve lock 70. As shown in FIG. 3 A, the proximal ends of detents 73 catch on a ledge on the distal end of plunger sleeve 40.
  • dose setting sleeve 80 is prevented from moving distally by an engagement with plunger sleeve 40. As shown in FIG. 1 IB, dose setting sleeve 80 has, toward its proximal end, protrusions 83 that engage with grooves 43 in plunger sleeve 40.
  • latch 52 of plunger 50 engages with the plunger sleeve so as to prevent further proximal movement of plunger 50.
  • the inclined surface of latch 52 allows for distal, but not proximal, movement of plunger 50 in this position. This prevents plunger 50 from backing out of the injector 1.
  • finger 49 is prevented from contracting inward by distal circumferential surface 57 of plunger 50. That is, surface 57 blocks finger 49 from moving inward. Finger 49 in turn prevents release adaptor 30 from moving proximally due to the contact of inwardly-protruding surface 35 with finger 49. That is, finger 49 blocks proximal movement of release adaptor 30. As such, a user is unable to attach a needle assembly in the initial position because protrusions 31 cannot move proximally to allow the assembly to attach to outer casing 20.
  • Step 1 A user triggers the first step, mixing, by advancing plunger 50 distally, as shown in FIG. 4. Distal movement of plunger 50 allows the plunger's distal-most end to engage with first piston 1 1, thereby advancing first piston 11 distally within medicament cartridge 10. Movement of piston 11 also advances the liquid medicament, which advances second piston 12 and solid medicament 17.
  • plunger 50 has advanced piston 12 past the proximal end of overflow channel 14, liquid medicament/solvent contained between pistons 11 and 12 flows through channel 14 around second piston 12, thereby mixing with solid medicament/solute 17, dissolving the solid into the liquid.
  • latch 52 of plunger 50 is pressed inward to allow distal movement of plunger 50, as shown in FIG. 5.
  • plunger 50 advances at this point so as to be recessed or counter-sunk within a proximal recess or opening in dose setting sleeve 80. Also, in this position, latch 52 of plunger 50 engages with a distal edge of plunger sleeve 40, thereby preventing backing out of plunger 50.
  • finger 49 snaps or otherwise contracts radially inwardly into groove 55. This releases the engagement of finger 49 with surface 35, thereby allowing the release adaptor to advance proximally.
  • Surface 35 may be inclined, as shown in the figures, so that, as release adaptor 30 advances proximally, surface 35 can push finger 49 radially inward if finger 49 fails to contract on its own.
  • finger 49 may also have an inclined surface (as shown in FIG. 5) that facilitates this action.
  • needle attachment As shown in FIGS. 6A and 6B, a user attaches a needle assembly 90 to the distal end of outer casing 20 via attachment mechanism 25. Attachment of needle assembly 90 causes the proximal end of needle 93 to pierce the septum membrane of medicament cartridge 10, as shown in FIG. 7. Piercing of medicament cartridge 10 relieves a portion of the pressure inside cartridge 10. (This pressure release may cause second piston 12 to advance distally.) After attaching the needle, a user removes a needle sheath 91, revealing a needle 93, as shown in FIG. 6C.
  • a user is permitted to begin the fourth step: dose setting.
  • dose setting As shown in FIG. 9A, a user selects a desired dose by rotating dose setting sleeve 80. Rotating setting sleeve 80 also rotates plunger sleeve 40 (due to their coupling via grooves 43). A user may change doses by rotating the dose setting sleeve 80 any number of times prior to beginning injection.
  • a user After dose selection, a user is able to proceed to the final step: injection. Now that key guide 41 is aligned with dosing groove 61a, a user may further advance plunger 50 (along with plunger sleeve 40 and dose setting sleeve 80, which are attached to plunger 50) in the distal direction. This distal movement further advances pistons 11 and 12, as shown in FIG. 11 A, thereby injecting the mixed medicament to the injection site.
  • the end-of-dose-indicating tab 71 on sleeve lock 70 slides across an inclined surface of and snaps behind dose end tab 47a. This provides haptic and/or audible feedback to a user, thereby indicating that the injection has completed. The engagement of tab 71 with tab 47a also prevents backing out of plunger sleeve 40 upon completion of injection.
  • plunger sleeve 40 (along with plunger 50 and dose setting sleeve 80) is prevented from further distal movement by dosing groove 61a. That is, guide key 41 has reached the end of dosing groove 61a and can no longer advance distally. Therefore, once injection is complete, plunger sleeve 40, plunger SO, and dose setting sleeve 80 are prevented from both distal and proximal movement.
  • a user of the previously described injector is prohibited from performing the injection sequence out of turn. That is, due to the contact of finger 49 with surface 57 in the initial position, a user is unable to attach a needle assembly until mixing is complete.
  • sleeve lock 70 with plunger sleeve 40, a user is unable to select a dose or to inject the medicament until needle assembly 90 is attached. Further, due to the engagement of guide key 41 with a proximal surface of rear body 60, a user cannot inject the medicament until a dose is selected. This provides a significant improvement over typical manual injectors, which allow users to perform steps out of order.
  • Certain embodiments of the present invention also provide a method of injecting a medicament.
  • One example of a method in accordance with the present invention includes the steps of providing an injector having the components discussed previously, attaching a needle assembly to the attachment mechanism of the injector, priming the injector after attaching the needle assembly, selecting a dose after priming the injector, and injecting the dose to an injection site. After injection, the user may wait a prescribed period of time (such as five seconds) before removing the injector from the injection site. The prescribed time period may be shortened, lengthened, or omitted altogether based on the particular application.
  • attaching the needle assembly causes distal movement of the release adaptor by forcing the one or more protrusions of the release adaptor through the one or more through holes of the outer casing.
  • the distal movement of the release adaptor in turn causes the at least one detent of the sleeve lock to release the plunger sleeve, which allows distal movement of the plunger sleeve, thereby permitting a user to proceed to the priming step.
  • a user is unable to prime the injector before inserting the needle assembly.
  • the step of selecting a dose includes rotating the dose setting sleeve, and the plunger sleeve rotatably fixed thereto, to align the key guide with one of the plurality of dosing grooves, as shown in FIG. 9B.
  • This permits further distal movement of the key guide, and therefore the plunger sleeve, allowing a user to inject the selected dose.
  • this step is performed after priming the injector but prior to injecting a dose.
  • Yet another embodiment of a method in accordance with the present invention involves a step of mixing a first medicament and a second medicament within the
  • This step preferably occurs prior to attaching the needle assembly.
  • the mixing can incur in the manner described above; that is, mixing may occur by depressing a plunger so as to advance a piston beyond an overflow channel in the medicament cartridge, as shown in FIG. 4.
  • the finger of the plunger sleeve prior to the mixing of the solid and liquid medicaments, the finger of the plunger sleeve is prevented from radially contracting into the groove of the plunger by a distal circumferential surface of the plunger.
  • the release adaptor is prevented from moving proximally by contact of the finger with an inwardly- protruding surface at the proximal end of the release adaptor.
  • the finger contracts into the groove of the plunger, thereby allowing proximal movement of the release adaptor.
  • injectors and methods in accordance with the present invention may be used to treat a broad range of diseases, disorders, and other medical conditions.
  • the injector may be used to treat hepatitis C.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention concerne un injecteur qui empêche un utilisateur de réaliser certaines étapes d'une séquence d'injection dans le désordre. Ledit injecteur comprend les éléments suivants : un boîtier externe pourvu d'un ou de plusieurs trous sur son extrémité distale ; un adaptateur de libération doté d'une ou de plusieurs saillies sur son extrémité distale ; un dispositif de blocage de manchon possédant au moins un cran flexible ; et un manchon de piston. La fixation d'un ensemble aiguille à l'injecteur entraîne le mouvement distal de l'adaptateur de libération, en forçant le passage des saillies des adaptateurs de libération à travers les boîtiers externes par les trous. Le mouvement distal de l'adaptateur de libération entraîne à son tour la libération du manchon de piston par le cran du dispositif de blocage de manchon. Ceci provoque le mouvement distal du manchon de piston, permettant ainsi à un utilisateur d'amorcer l'injecteur. Ainsi, l'utilisateur ne peut pas amorcer l'injecteur ni commencer une injection avant de fixer l'ensemble aiguille.
PCT/US2012/026239 2011-02-28 2012-02-23 Injecteur actionné manuellement avec séquence d'injection limitée WO2012118687A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161447333P 2011-02-28 2011-02-28
US61/447,333 2011-02-28

Publications (1)

Publication Number Publication Date
WO2012118687A1 true WO2012118687A1 (fr) 2012-09-07

Family

ID=46758265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/026239 WO2012118687A1 (fr) 2011-02-28 2012-02-23 Injecteur actionné manuellement avec séquence d'injection limitée

Country Status (1)

Country Link
WO (1) WO2012118687A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014056635A1 (fr) * 2012-10-08 2014-04-17 Tecpharma Licensing Ag Dispositif d'injection pourvu d'un moyen de commande de dose
WO2014154491A1 (fr) * 2013-03-25 2014-10-02 Carebay Europe Ltd Verrouillage de bloc d'alimentation
WO2014166890A1 (fr) * 2013-04-10 2014-10-16 Sanofi Dispositif d'injection
US9302052B1 (en) * 2013-04-30 2016-04-05 Karim Timothy Rafaat Pre-loaded syringe with metered dosing and methods of use
WO2017053175A1 (fr) * 2015-09-21 2017-03-30 Merck Sharp & Dohme Corp. Stylo d'injection à reconstitution de substance sèche par voie humide
WO2018085759A1 (fr) 2016-11-07 2018-05-11 Beloteca, Inc. Système d'administration de médicament à dose réglable
WO2018141633A1 (fr) * 2017-02-03 2018-08-09 Norton Healthcare Limited Ensemble pour un dispositif de distribution de médicament et dispositif de distribution de médicament
WO2018141634A1 (fr) * 2017-02-03 2018-08-09 Norton Healthcare Limited Ensemble destiné à un dispositif d'administration de médicament et dispositif d'administration de médicament
WO2019222713A1 (fr) * 2018-05-18 2019-11-21 Bard Peripheral Vascular, Inc. Dispositif d'administration de radio-embolisation
US10850036B2 (en) 2015-08-27 2020-12-01 E3D Agricultural Cooperative Association Reusable automatic injection device
CN114340580A (zh) * 2019-07-30 2022-04-12 伊奎希尔德医疗有限公司 开放液体药物转移系统的组件以及采用所述组件的机器人系统
CN114867510A (zh) * 2019-12-11 2022-08-05 赛诺菲 注射装置
CN115054777A (zh) * 2017-06-08 2022-09-16 诺瓦提斯公司 注射装置及注射液输送系统
US11534555B2 (en) 2017-02-03 2022-12-27 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device comprising such an assembly
US11771836B2 (en) 2017-02-03 2023-10-03 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device
US11862331B2 (en) 2011-03-24 2024-01-02 Sanofi-Aventis Deutschland Gmbh Device and method for detecting an actuation action performable with a medical device
US11865306B2 (en) 2014-02-10 2024-01-09 E3D A.C.A.L Ltd Semi disposable auto injector
US11904181B2 (en) 2018-05-18 2024-02-20 Bard Peripheral Vascular, Inc. Systems and methods for use of a dosimetry application software tool to customize dosimetry and sphere selection for radioembolization procedure planning
US11944796B2 (en) 2015-06-09 2024-04-02 Sanofi-Aventis Deutschland Gmbh Data collection apparatus for attachment to an injection device

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407283A (en) * 1981-10-19 1983-10-04 Dale C. Grier Self-injecting syringe
US5209732A (en) * 1989-03-17 1993-05-11 Merit Medical Systems, Inc. Locking syringe with thread-release lock
US5304137A (en) * 1993-05-07 1994-04-19 Fluke Gary L Safety syringe
US5399170A (en) * 1989-05-04 1995-03-21 Western Medical Products Pty Limited Syringe
US5921966A (en) * 1997-08-11 1999-07-13 Becton Dickinson And Company Medication delivery pen having an improved clutch assembly
US5971953A (en) * 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
US6142972A (en) * 1994-09-02 2000-11-07 Delab Method and apparatus for the delivery of elongate solid drug compositions
US6945958B2 (en) * 2001-11-14 2005-09-20 Sherwood Services Ag Safety needle apparatus
US7402150B2 (en) * 2005-09-05 2008-07-22 Jcr Pharmaceuticals Co., Ltd. Injection device
US7632491B2 (en) * 2004-08-12 2009-12-15 Schering Corporation Stable pegylated interferon formulation

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407283A (en) * 1981-10-19 1983-10-04 Dale C. Grier Self-injecting syringe
US5209732A (en) * 1989-03-17 1993-05-11 Merit Medical Systems, Inc. Locking syringe with thread-release lock
US5399170A (en) * 1989-05-04 1995-03-21 Western Medical Products Pty Limited Syringe
US5304137A (en) * 1993-05-07 1994-04-19 Fluke Gary L Safety syringe
US6142972A (en) * 1994-09-02 2000-11-07 Delab Method and apparatus for the delivery of elongate solid drug compositions
US5921966A (en) * 1997-08-11 1999-07-13 Becton Dickinson And Company Medication delivery pen having an improved clutch assembly
US5971953A (en) * 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
US6945958B2 (en) * 2001-11-14 2005-09-20 Sherwood Services Ag Safety needle apparatus
US7632491B2 (en) * 2004-08-12 2009-12-15 Schering Corporation Stable pegylated interferon formulation
US7402150B2 (en) * 2005-09-05 2008-07-22 Jcr Pharmaceuticals Co., Ltd. Injection device

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11862331B2 (en) 2011-03-24 2024-01-02 Sanofi-Aventis Deutschland Gmbh Device and method for detecting an actuation action performable with a medical device
US10149945B2 (en) 2012-10-08 2018-12-11 Tecpharma Licensing Ag Injection device with dosing control means
US11141536B2 (en) 2012-10-08 2021-10-12 Ypsomed Ag Injection device with dosing control means
CN104684604A (zh) * 2012-10-08 2015-06-03 特克法马许可公司 具有定量控制装置的注射设备
WO2014056635A1 (fr) * 2012-10-08 2014-04-17 Tecpharma Licensing Ag Dispositif d'injection pourvu d'un moyen de commande de dose
WO2014154491A1 (fr) * 2013-03-25 2014-10-02 Carebay Europe Ltd Verrouillage de bloc d'alimentation
CN105188806A (zh) * 2013-03-25 2015-12-23 卡贝欧洲有限公司 电源组锁定
CN105102026A (zh) * 2013-04-10 2015-11-25 赛诺菲 注射装置
AU2014253259B2 (en) * 2013-04-10 2018-07-26 Sanofi Injection device
US11865311B2 (en) 2013-04-10 2024-01-09 Sanofi Injection device
US10478564B2 (en) 2013-04-10 2019-11-19 Sanofi Injection device
CN105102026B (zh) * 2013-04-10 2020-02-07 赛诺菲 注射装置
WO2014166890A1 (fr) * 2013-04-10 2014-10-16 Sanofi Dispositif d'injection
US9302052B1 (en) * 2013-04-30 2016-04-05 Karim Timothy Rafaat Pre-loaded syringe with metered dosing and methods of use
US11865306B2 (en) 2014-02-10 2024-01-09 E3D A.C.A.L Ltd Semi disposable auto injector
US11944796B2 (en) 2015-06-09 2024-04-02 Sanofi-Aventis Deutschland Gmbh Data collection apparatus for attachment to an injection device
US11786658B2 (en) 2015-08-27 2023-10-17 E3D A.C.A.L. Ltd Reusable automatic injection device
US10850036B2 (en) 2015-08-27 2020-12-01 E3D Agricultural Cooperative Association Reusable automatic injection device
WO2017053175A1 (fr) * 2015-09-21 2017-03-30 Merck Sharp & Dohme Corp. Stylo d'injection à reconstitution de substance sèche par voie humide
EP3534987A4 (fr) * 2016-11-07 2020-04-01 Beloteca, Inc. Système d'administration de médicament à dose réglable
WO2018085759A1 (fr) 2016-11-07 2018-05-11 Beloteca, Inc. Système d'administration de médicament à dose réglable
WO2018141634A1 (fr) * 2017-02-03 2018-08-09 Norton Healthcare Limited Ensemble destiné à un dispositif d'administration de médicament et dispositif d'administration de médicament
US11389594B2 (en) 2017-02-03 2022-07-19 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device
US11376367B2 (en) 2017-02-03 2022-07-05 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device
US11534555B2 (en) 2017-02-03 2022-12-27 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device comprising such an assembly
US11771836B2 (en) 2017-02-03 2023-10-03 Norton Healthcare Limited Assembly for a medication delivery device and medication delivery device
WO2018141633A1 (fr) * 2017-02-03 2018-08-09 Norton Healthcare Limited Ensemble pour un dispositif de distribution de médicament et dispositif de distribution de médicament
CN115054777A (zh) * 2017-06-08 2022-09-16 诺瓦提斯公司 注射装置及注射液输送系统
WO2019222713A1 (fr) * 2018-05-18 2019-11-21 Bard Peripheral Vascular, Inc. Dispositif d'administration de radio-embolisation
US11904181B2 (en) 2018-05-18 2024-02-20 Bard Peripheral Vascular, Inc. Systems and methods for use of a dosimetry application software tool to customize dosimetry and sphere selection for radioembolization procedure planning
EP4252818A3 (fr) * 2018-05-18 2024-03-27 Bard Peripheral Vascular, Inc. Dispositif d'administration de radio-embolisation
CN114340580A (zh) * 2019-07-30 2022-04-12 伊奎希尔德医疗有限公司 开放液体药物转移系统的组件以及采用所述组件的机器人系统
CN114867510A (zh) * 2019-12-11 2022-08-05 赛诺菲 注射装置

Similar Documents

Publication Publication Date Title
WO2012118687A1 (fr) Injecteur actionné manuellement avec séquence d'injection limitée
US11819670B2 (en) Auto-injector
JP7252966B2 (ja) 安全針カバーを備えた組成物を注入するための医療デバイス
US10213557B2 (en) Medicament delivery device and method of controlling the device
AU2012217077B2 (en) Auto-injector
RU2607939C2 (ru) Автоматический инъектор
RU2607528C2 (ru) Автоматический инъектор
RU2607529C2 (ru) Автоматический инъектор
DK2675508T3 (en) autoinjector
JP6006645B2 (ja) 注射デバイス
JP5807021B2 (ja) 自動注射器
DK2675504T3 (en) autoinjector
US20160106923A1 (en) Injection Device
RU2620353C2 (ru) Автоинъектор
KR20150071705A (ko) 자동주사기
JP2021503983A (ja) 薬物送達デバイスのための駆動サブアセンブリ
JP2013506456A (ja) 薬物送達デバイスで使用するためのアセンブリ
CN115038480A (zh) 可变剂量注射筒
KR20150073185A (ko) 표시부를 사용하는 약제 전달 장치
CN106413783B (zh) 用于药物输送装置的壳体和药物输送装置
CN106456886A (zh) 用于输送两种药剂的药物输送装置
EP4072624A1 (fr) Dispositif d'injection
US20210187201A1 (en) Injection device with a preselector
WO2023078861A1 (fr) Dispositif supplémentaire avec mécanisme de verrouillage intégré
AU2012217082B2 (en) Auto-injector

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12752271

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12752271

Country of ref document: EP

Kind code of ref document: A1